Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Guggenheim 

Medpace Holdings Inc diskutieren

Medpace Holdings Inc

WKN: A2APTV / Symbol: MEDP / Name: Medpace Holdings / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /

475,30 €
-1,31 %

Einschätzung Buy
Rendite (%) 67,36 %
Kursziel 345,10
Veränderung
Endet am 23.10.25

Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target lowered by analysts at TD Cowen from $413.00 to $372.00. They now have a "buy" rating on the stock.
Ratings data for MEDP provided by MarketBeat

Einschätzung Buy
Rendite (%) 83,58 %
Kursziel 321,81
Veränderung
Endet am 09.04.26

Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target lowered by analysts at Mizuho from $400.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat

Einschätzung Sell
Rendite (%) 19,90 %
Kursziel 311,76
Veränderung
Endet am 23.07.26

Medpace Holdings, Inc. (NASDAQ: MEDP) had its "sell" rating re-affirmed by analysts at TD Cowen. They now have a $366.00 price target on the stock, up previously from $283.00.
Ratings data for MEDP provided by MarketBeat

Medpace Holdings, Inc. (NASDAQ: MEDP) was downgraded by analysts at Cowen Inc from a "buy" rating to a "sell" rating.
Ratings data for MEDP provided by MarketBeat

Einschätzung Buy
Rendite (%) 24,91 %
Kursziel 434,37
Veränderung
Endet am 25.07.26

Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Mizuho from $328.00 to $510.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat

Einschätzung Sell
Rendite (%) 26,01 %
Kursziel 263,00
Veränderung
Endet am 29.07.26

Medpace Holdings, Inc. (NASDAQ: MEDP) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating. They now have a $305.00 price target on the stock.
Ratings data for MEDP provided by MarketBeat

Einschätzung Buy
Rendite (%) -6,22 %
Kursziel 564,09
Veränderung
Endet am 24.10.26

Medpace (NASDAQ:MEDP) had its price target raised by analysts at Mizuho from $575.00 to $655.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat

Medpace (NASDAQ:MEDP) had its "sell" rating reaffirmed by analysts at Cowen Inc.
Ratings data for MEDP provided by MarketBeat

Einschätzung Sell
Rendite (%) -8,70 %
Kursziel 397,87
Veränderung
Endet am 24.10.26

Medpace (NASDAQ:MEDP) had its price target raised by analysts at TD Cowen from $356.00 to $462.00. They now have a "sell" rating on the stock.
Ratings data for MEDP provided by MarketBeat